Management options for localized prostate cancer have largely remained the same for the past 30 years. 90Yttrium (90Y) radioembolization is a novel radiotherapy approach that offers the potential to deliver high-dose radiation therapy with minimal non-target radiation. However, currently no accurate way exists to evaluate radiation effects noninvasively following embolization. In this study, we sought to apply diffusion and dynamic contrast-enhanced perfusion MRI to investigate assess the effects of treatment following 90Y prostate artery radioembolization in a dog prostate model.
This abstract and the presentation materials are available to members only; a login is required.